Hamilton Jasmine L, Hatef Azadeh, Imran ul-Haq Muhammad, Nair Neelima, Unniappan Suraj, Kizhakkedathu Jayachandran N
The Centre for Blood Research, Department of Pathology and Laboratory Medicine, Life Sciences Institute, The University of British Columbia, Vancouver, British Columbia, Canada.
Veterinary Biomedical Sciences, Laboratory of Integrative Neuroendocrinology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
PLoS One. 2014 Oct 16;9(10):e109880. doi: 10.1371/journal.pone.0109880. eCollection 2014.
Iron chelation therapy using iron (III) specific chelators such as desferrioxamine (DFO, Desferal), deferasirox (Exjade or ICL-670), and deferiprone (Ferriprox or L1) are the current standard of care for the treatment of iron overload. Although each chelator is capable of promoting some degree of iron excretion, these chelators are also associated with a wide range of well documented toxicities. However, there is currently very limited data available on their effects in developing embryos. In this study, we took advantage of the rapid development and transparency of the zebrafish embryo, Danio rerio to assess and compare the toxicity of iron chelators. All three iron chelators described above were delivered to zebrafish embryos by direct soaking and their effects on mortality, hatching and developmental morphology were monitored for 96 hpf. To determine whether toxicity was specific to embryos, we examined the effects of chelator exposure via intra peritoneal injection on the cardiac function and gene expression in adult zebrafish. Chelators varied significantly in their effects on embryo mortality, hatching and morphology. While none of the embryos or adults exposed to DFO were negatively affected, ICL -treated embryos and adults differed significantly from controls, and L1 exerted toxic effects in embryos alone. ICL-670 significantly increased the mortality of embryos treated with doses of 0.25 mM or higher and also affected embryo morphology, causing curvature of larvae treated with concentrations above 0.5 mM. ICL-670 exposure (10 µL of 0.1 mM injection) also significantly increased the heart rate and cardiac output of adult zebrafish. While L1 exposure did not cause toxicity in adults, it did cause morphological defects in embryos at 0.5 mM. This study provides first evidence on iron chelator toxicity in early development and will help to guide our approach on better understanding the mechanism of iron chelator toxicity.
使用铁(III)特异性螯合剂如去铁胺(DFO,去铁敏)、地拉罗司(Exjade或ICL - 670)和去铁酮(Ferriprox或L1)进行铁螯合疗法是目前治疗铁过载的标准治疗方法。尽管每种螯合剂都能够促进一定程度的铁排泄,但这些螯合剂也与一系列有充分记录的毒性相关。然而,目前关于它们对发育中胚胎影响的数据非常有限。在本研究中,我们利用斑马鱼胚胎(Danio rerio)发育迅速且透明的特点来评估和比较铁螯合剂的毒性。通过直接浸泡将上述三种铁螯合剂施用于斑马鱼胚胎,并在受精后96小时内监测它们对死亡率、孵化率和发育形态的影响。为了确定毒性是否对胚胎具有特异性,我们通过腹腔注射螯合剂来检查其对成年斑马鱼心脏功能和基因表达的影响。螯合剂对胚胎死亡率、孵化率和形态的影响差异显著。虽然暴露于DFO的胚胎或成年鱼均未受到负面影响,但ICL处理的胚胎和成年鱼与对照组有显著差异,而L1仅对胚胎产生毒性作用。ICL - 670显著增加了用0.25 mM或更高剂量处理的胚胎的死亡率,并且还影响胚胎形态,导致用高于0.5 mM浓度处理的幼虫出现弯曲。ICL - 670暴露(注射10 μL 0.1 mM)也显著增加了成年斑马鱼的心率和心输出量。虽然L1暴露对成年鱼没有造成毒性,但在0.5 mM时确实导致胚胎出现形态缺陷。本研究首次提供了关于铁螯合剂在早期发育中的毒性证据,并将有助于指导我们更好地理解铁螯合剂毒性机制的研究方法。